Jacqueline E. Shea

2021

In 2021, Jacqueline E. Shea earned a total compensation of $2.3M as Chief Operating Officer at Inovio Pharmaceuticals, a 8% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$218,442
Option Awards$860,581
Salary$467,585
Stock Awards$750,726
Other$12,823
Total$2,310,157

Shea received $860.6K in option awards, accounting for 37% of the total pay in 2021.

Shea also received $218.4K in non-equity incentive plan, $467.6K in salary, $750.7K in stock awards and $12.8K in other compensation.

Rankings

In 2021, Jacqueline E. Shea's compensation ranked 5,469th out of 12,406 executives tracked by ExecPay. In other words, Shea earned more than 55.9% of executives.

ClassificationRankingPercentile
All
5,469
out of 12,406
56th
Division
Manufacturing
2,308
out of 5,492
58th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
280
out of 798
65th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
168
out of 519
68th
Industry
Surgical and Medical Instruments and Apparatus
108
out of 324
67th

Pay ratio

Jacqueline E. Shea's Pay$2,310,157
Median Employee's Pay$180,313
Pay Ratio

13

to 1

In 2021, the annual total compensation of Jacqueline E. Shea was $2,310,157.

The annual total compensation of the median employee at Inovio Pharmaceuticals was $180,313.

The ratio of Jacqueline E. Shea's pay to the pay of median employee was therefore 13 to one.

Source: SEC filing on March 25, 2022.

Shea's colleagues

We found three more compensation records of executives who worked with Jacqueline E. Shea at Inovio Pharmaceuticals in 2021.

2021

J Kim

Inovio Pharmaceuticals

Chief Executive Officer

2021

Peter Kies

Inovio Pharmaceuticals

Chief Financial Officer

2021

Laurent Humeau

Inovio Pharmaceuticals

Chief Scientific Officer

News

You may also like